Arkansas Legislative Intelligence
Senate
94th General Assembly (2023 Regular)
Passed

SB181

To Mandate Coverage For Use Of Intravenous Immunoglobulin To Treat Certain Pediatric Disorders Caused By Infections; And To Declare An Emergency.

To Mandate Coverage For Use Of Intravenous Immunoglobulin To Treat Certain Pediatric Disorders Caused By Infections; And To Declare An Emergency.

Bill Summary

To Mandate Coverage For Use Of Intravenous Immunoglobulin To Treat Certain Pediatric Disorders Caused By Infections; And To Declare An Emergency.
Influence Proximity
1st Degree Direct
2nd Degree Shared
3rd Degree Extended

Network Filters

SB181: To Mandate Coverage For Use Of Intravenous Immunoglobulin To Treat Certain Pediatric Disorders Caused By Infections; And To Declare An Emergency. - Arkansas Legislature | StateLeg